Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology

31 Aug 2015

Abstract excerpt

AIM: Long non-coding RNAs (lncRNAs) are potential biomarkers for breast cancer risk stratification. LncRNA expression has been investigated primarily by RNA sequencing, quantitative reverse transcription PCR or microarray techniques. In this study, six breast cancer-implicated lncRNAs were investigated by chromogenic in situ hybridisation (CISH). METHODS: Invasive breast carcinoma (IBC), ductal carcinoma in situ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to Kruppel-like factors research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26323944
DOI: 10.1136/jclinpath-2015-203275

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathologyPMID 26323944Read ↗

Long-Noncoding-RNA HOTAIR Upregulation is Associated with Poor Breast Cancer Outcome: A Systematic Review and Meta AnalysisSemantic proximity Read ↗

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring studySemantic proximity Read ↗

HER2 Positivity in Breast Carcinoma: A Comparison of Chromogenic In Situ Hybridization With Fluorescence In Situ Hybridization in Tissue Microarrays, With Targeted Evaluation of Intratumoral Heterogeneity by In Situ HybridizationSemantic proximity Read ↗

Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung.Semantic proximity Read ↗

Interlaboratory Comparison of<b><i>HER-2</i></b>Oncogene Amplification as Detected by Chromogenic and Fluorescence<b><i>in situ</i></b>HybridizationSemantic proximity Read ↗

Chromogenic In Situ HybridizationSemantic proximity Read ↗

Conserved structural features of the lncRNA HOTAIR in breast cancer cellsSemantic proximity Read ↗

Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancerSemantic proximity Read ↗

Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinomaSemantic proximity Read ↗

Determination of <i>HER2</i> amplification in primary breast cancer using dual‐colour chromogenic <i>in situ</i> hybridization is comparable to fluorescence <i>in situ</i> hybridization: a European multicentre study involving 168 specimensSemantic proximity Read ↗

Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation enables accurate assessment of HER2 genomic status in ovarian tumoursSemantic proximity Read ↗

Chromogenic in-situ hybridization: a viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithmSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.